Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.

Ullmann, A J; Cornely, O A; Burchardt, A; Hachem, R; Kontoyiannis, D P; Töpelt, K; Courtney, R; Wexler, D; Krishna, G; Martinho, M; Corcoran, G; Raad, I

Ullmann, A J; Cornely, O A; Burchardt, A; Hachem, R; Kontoyiannis, D P; Töpelt, K; Courtney, R; Wexler, D; Krishna, G; Martinho, M; Corcoran, G; Raad, I.

Affiliation

Ullmann AJ; Third Medical Department, Johannes Gutenberg-University, Mainz, Germany. a.ullmann@3-med.klinik.uni-mainz.de

Antimicrob Agents Chemother ; 50(2): 658-66, 2006 Feb.

Article in En | MEDLINE | ID: mdl-16436724

Subject(s)

Antifungal Agents/pharmacokinetics; Fever/drug therapy; Mycoses/drug therapy; Neutropenia/complications; Triazoles/pharmacokinetics; Adult; Aged; Bone Marrow Transplantation; Female; Humans; Male; Middle Aged; Triazoles/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Fever / Mycoses / Antifungal Agents / Neutropenia Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2006 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google